Phase 2 of the Norwich COVID-19 testing initiative: an evaluation
J Public Health (Oxf)
.
2021 Dec 10;43(4):e749-e750.
doi: 10.1093/pubmed/fdab124.
Authors
T Berger Gillam
1
,
J Chin
2
,
S Cossey
3
,
K Culley
4
,
R K Davidson
5
,
D R Edwards
5
,
K Gharbi
3
,
N Goodwin
4
,
N Hall
3
6
,
M Hitchcock
7
,
O J Jupp
8
,
J Lipscombe
3
,
G Parr
2
,
N Shearer
3
,
R Smith
2
,
N Steel
1
Affiliations
1
Health Services and Primary Care Research Group, University of East Anglia, Norwich NR4 7TJ, UK.
2
School of Computing Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
3
Earlham Institute, Norwich NR4 7UZ, UK.
4
Anglia Innovation Partnership LLP, Centrum, Norwich Research Park, Norwich NR4 7UG, UK.
5
Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7UQ, UK.
6
UEA Biosciences, University of East Anglia, Norwich NR4 7TJ, UK.
7
UEA Health and Social Care Partners, University of East Anglia, Norwich NR4 7TJ, UK.
8
BCRE CTC, Norfolk and Norwich University Foundation Hospital Microbiology Department, Norwich NR4 7GJ, UK.
PMID:
33839796
PMCID:
PMC8083310
DOI:
10.1093/pubmed/fdab124
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Testing*
COVID-19*
Humans
SARS-CoV-2